DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Triple-Negative Breast Carcinoma
Interventions: PROCEDURE: Dynamic Contrast-Enhanced Magnetic Resonance Imaging|OTHER: Laboratory Biomarker Analysis|RADIATION: Scintimammography|DRUG: Technetium Tc-99m Sestamibi
Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)